Here, we study the possible existence, both in cultured cells and in mouse striatum, of a physical AT1R-A2AR interaction, which may be a potential target for managing dopaminergic-related disorders (i.e. tardive dyskinesia, TD). The gene discussed is ADORA2A; the disease is thanatophoric dysplasia.